Inhibicor

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameInhibicor
Drug Alias Nameanti-TL1-A Mab (Heat Biologics)IN-A1
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionTumor necrosis factor receptor superfamily member 25 antagonistsTumor necrosis factor superfamily member 15 inhibitors
TargetsTumor necrosis factor superfamily member 15Tumor necrosis factor receptor superfamily member 25
Therapy Area/IndicationsRejection of organ transplantationAutoimmune DiseasesAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesScorpius Holdings Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesScorpius Holdings Inc
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationAutoimmune DiseasesAsthma

Other Information

ATC CodeN/A
Related LinksN/A